The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa
Open accessAbstract
OBJECTIVE: To determine the short-term and long-term risks of tuberculosis (TB) associated with CD4 cell recovery during antiretroviral therapy (ART). DESIGN: Observational community-based ART cohort in South Africa. METHODS: TB incidence was determined among patients (n = 1480) receiving ART for up to 4.5 years in a South African community-based service. Updated CD4 cell counts were measured 4-monthly. Person-time accrued within a range of CD4 cell count strata (CD4 cell strata) was calculated and used to derive CD4 cell-stratified TB rates. Factors associated with incident TB were identified using Poisson regression models. RESULTS: Two hundred and three cases of TB were diagnosed during 2785 person-years of observation (overall incidence, 7.3 cases/100 person-years). During person-time accrued within CD4 cell strata 0-100, 101-200, 201-300, 301-400, 401-500 and more than 500 cells/microl unadjusted TB incidence rates were 16.8, 9.3, 5.5, 4.6, 4.2 and 1.5 cases/100 person-years, respectively (P < 0.001). During early ART (first 4 months), adjusted TB rates among those with CD4 cell counts 0-200 cells/microl were 1.7-fold higher than during long-term ART (P = 0.026). Updated CD4 cell counts were the only patient characteristic independently associated with long-term TB risk. CONCLUSION: Updated CD4 cell counts were the dominant predictor of TB risk during ART in this low-resource setting. Among those with baseline CD4 cell counts less than 200 cells/microl, the excess adjusted risk of TB during early ART was consistent with 'unmasking' of disease missed at baseline screening. TB incidence rates at CD4 cell counts of 200-500 cells/microl remained high and adjunctive interventions are required. TB prevention would be improved by ART policies that minimized the time patients spend with CD4 cell counts below a threshold of 500 cells/microl.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732
Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review
Rosen, S., Fox, M. P., & Gill, C. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040298 · Cited by 796
Meintjes, G., Lawn, S. D., Scano, F., Maartens, G., French, M. A., Worodria, W., Elliott, J. H., Murdoch, D., Wilkinson, R. J., Seyler, C., et al. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70184-1 · Cited by 745
Self-citationEarly mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa
Lawn, S. D., Harries, A. D., Anglaret, X., Myer, L., & Wood, R. (2008) · AIDS · doi:10.1097/qad.0b013e32830007cd · Cited by 639
Self-citationBadri, M., Wilson, D., & Wood, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08904-3 · Cited by 556
Self-citationLawn, S. D., Bekker, L.-G., & Miller, R. F. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70140-7 · Cited by 545
Self-citationLedergerber, B., Egger, M., Erard, V., Weber, R., Hirschel, B., Furrer, H., Battegay, M., Vernazza, P., Bernasconi, E., Opravil, M., et al. (1999) · JAMA · doi:10.1001/jama.282.23.2220 · Cited by 481
Lawn, S. D., Myer, L., Bekker, L.-G., & Wood, R. (2006) · AIDS · doi:10.1097/01.aids.0000238406.93249.cd · Cited by 363
Self-citationLawn, S. D., Myer, L., Orrell, C., Bekker, L.-G., & Wood, R. (2005) · AIDS · doi:10.1097/01.aids.0000194802.89540.e1 · Cited by 359
Self-citationLawn, S. D., Badri, M., & Wood, R. (2005) · AIDS · doi:10.1097/01.aids.0000194808.20035.c1 · Cited by 352
Self-citation
Cited by
Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.76 · Cited by 1,270
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
The TEMPRANO ANRS 12136 Study Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507198 · Cited by 1,242
Lawn, S. D., & Zumla, A. I. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62173-3 · Cited by 751
Self-citationHIV and Tuberculosis: a Deadly Human Syndemic
Kwan, C. K., & Ernst, J. D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-10 · Cited by 720
“However, despite ART treatment, the overall TB incidence rate for HIV-infected patients still remained approximately 10-fold higher than that for adults without HIV (156).”
BackgroundMethodInfluentialUnderstanding Latent Tuberculosis: A Moving Target
Lin, P. L., & Flynn, J. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903856 · Cited by 488
Immunological biomarkers of tuberculosis
Walzl, G., Ronacher, K., Hanekom, W., Scriba, T. J., & Zumla, A. (2011) · Nature Reviews Immunology · doi:10.1038/nri2960 · Cited by 477
Macrophages and control of granulomatous inflammation in tuberculosis
Flynn, J. L., Chan, J., & Lin, P. L. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.14 · Cited by 417
Suthar, A. B., Lawn, S. D., del Amo, J., Getahun, H., Dye, C., Sculier, D., Sterling, T. R., Chaisson, R. E., Williams, B. G., Harries, A. D., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001270 · Cited by 402
Self-citationEarly versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti
Severe, P., Jean Juste, M. A., Ambroise, A., Eliacin, L., Marchand, C., Apollon, S., Edwards, A., Bang, H., Nicotera, J., Godfrey, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0910370 · Cited by 377
Samandari, T., Agizew, T. B., Nyirenda, S., Tedla, Z., Sibanda, T., Shang, N., Mosimaneotsile, B., Motsamai, O. I., Bozeman, L., Davis, M. K., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60204-3 · Cited by 355
Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis
Cavalcanti, Y. V. N., Brelaz, M. C. A., Lemoine Neves, J. K. D. A., Ferraz, J. C., & Pereira, V. R. A. (2012) · Pulmonary Medicine · doi:10.1155/2012/745483 · Cited by 324
Lawn, S. D., Brooks, S. V., Kranzer, K., Nicol, M. P., Whitelaw, A., Vogt, M., Bekker, L.-G., & Wood, R. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001067 · Cited by 278
Self-citationFunctional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis
Prezzemolo, T., Guggino, G., La Manna, M. P., Di Liberto, D., Dieli, F., & Caccamo, N. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00180 · Cited by 267
HIV-1/ Mycobacterium tuberculosis Coinfection Immunology: How Does HIV-1 Exacerbate Tuberculosis?
Diedrich, C. R., & Flynn, J. L. (2011) · Infection and Immunity · doi:10.1128/iai.01126-10 · Cited by 266
Bjerrum, S., Schiller, I., Dendukuri, N., Kohli, M., Nathavitharana, R. R., Zwerling, A. A., Denkinger, C. M., Steingart, K. R., & Shah, M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011420.pub3 · Cited by 186
“…studied Kroidi 2014 Index test not studied Kroidl 2015 Paediatric population LaCourse 2018a Paediatric population LaCourse 2018b Paediatric population Lawn 2009a Index test not studied Lawn 2012a Did not use manufacturer's current recommended positivity threshold Lawn 2012b Insufficient or…”
BackgroundInfluential
Metadata
- Authors
- Lawn, S. D., Myer, L., Edwards, D., Bekker, L.-G., & Wood, R.
- Venue
- AIDS
- Published
- 2009-08-24
- Volume
- 23
- Issue
- 13
- Pages
- 1717-1725
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2091328187
- Cited by
- 338
- References
- 35
- FWCI
- 23.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.